Reference Genomics, Inc.

Defense · Acquired by Invitae Corporation (2021)

Metagenomic analysis platform for detecting nuclear weapons development sites through microbial community profiling

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Defense
Total capital
$150K
Federal grants
$150K
1 award · 2017
Rank in peer group#6 of 88
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
1
3 pending · first 2018
Rank in peer group#15 of 88

Capital timeline

2017FEDERAL ↑EQUITY ↓Cumulative $150K$150K
2017FEDERAL ↑EQUITY ↓Cumulative $150K$150K

Latest events

  • Federal grantDefense · Phase I · Bioinformatics: Data Integration for Biomonitoring Applications$150K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

1 record has no date or no amount, so it isn’t placed on the timeline.

Standing among 88 peers

Line = median

Defense · Software

  • Federal grants#6 · top 7%
  • Granted patents#15 · top 17%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 1 granted of 4
Show all 4 patent records
  • System And Method For Application Of Enhanced Controls With A Genomic Computing PlatformMay 14, 2020 · Application 16600226Pending
  • System And Method For Characterizing Data Through A Probabilistic Data StructureMay 17, 2018 · Application 15860426Pending
  • System And Method For Characterizing Biological Sequence Data Through A Probabilistic Data StructureFeb 13, 2018 · US 9,892,237Granted
  • System And Method For Application Of An Enhanced Spike-in Control With A Genomic Computing PlatformApplication 62744412Pending

Regulatory activity · Defense

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .